Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
Nannan Liu, Xinxiu Jiang, Leiming Guo, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2419-2438
Open Access | Times Cited: 13

Showing 13 citing articles:

p53 at the crossroads of tumor immunity
Gizem Efe, Anil K. Rustgi, Carol Prives
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 983-995
Closed Access | Times Cited: 15
TRIM22 induces cellular senescence by targeting PHLPP2 in hepatocellular carcinoma
Donghee Kang, Hyun Jung Hwang, Yurim Baek, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Metastatic outgrowth via the two-way interplay of autophagy and metabolism
Amir Barzegar Behrooz, Marco Cordani, Massimo Donadelli, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 3, pp. 166824-166824
Closed Access | Times Cited: 22
CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription
Z.H Wang, Yaming Li, H. J. Yang, et al.
Advanced Science (2024)
Open Access | Times Cited: 7
The Role of Tumor Metabolic Reprogramming in Tumor Immunity
Xianhong Zhang, Weiguo Song, Yue Gao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17422-17422
Open Access | Times Cited: 16
LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53‐driven tumour progression through miR‐5683/FGF2
Nannan Liu, Xinxiu Jiang, Ge Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 6
Identification of a novel prognostic marker ADGRG6 in pancreatic adenocarcinoma: multi-omics analysis and experimental validation
Han Wu, Jin Shang, Yuxin Bao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines
Jong‐Seo Yoon, Haeun Moon, Yong Tark Jeon, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4559-4559
Open Access
Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9592-9592
Open Access | Times Cited: 13
LncRNA SLC7A11-AS1 promotes the progression of hepatocellular carcinoma by mediating KLF9 ubiquitination
Fan‐Lin Zeng, Jie Lin, Xing Xie, et al.
Neoplasma (2023) Vol. 70, Iss. 03, pp. 361-374
Open Access | Times Cited: 8
Newcastle disease virus activates the PI3K/AKT signaling pathway by targeting PHLPP2 degradation to delay cell apoptosis and promote viral replication
Lei Fan, Zhaoping Liang, Jinlian Ren, et al.
Veterinary Microbiology (2023) Vol. 289, pp. 109949-109949
Closed Access | Times Cited: 4
LncRNA CARMN m6A Demethylation by ALKBH5 Inhibits Mutant p53-Driven Tumor Progression through miR-5683/FGF2
Yingjie Zhang, Nannan Liu, Xinxiu Jiang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Research advances in signaling pathways related to the malignant progression of HSIL to invasive cervical cancer: A review
Huifang Wang, Chang Liu, Keer Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117483-117483
Open Access
Page 1

Scroll to top